Results 11 to 20 of about 50,152 (259)

Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use

open access: yesAddiction Science & Clinical Practice, 2023
Background We use a novel, longitudinal approach to describe average time spent in opioid use disorder (OUD) cascade of care stages for people with HIV (PWH) and with OUD, incorporating four definitions of treatment retention.
Jarratt D. Pytell   +7 more
doaj   +1 more source

Buprenorphine Waiver Attitudes Among Primary Care Providers

open access: yesJournal of Primary Care & Community Health, 2022
Background: Despite efforts to improve access to Medications for Opioid Use Disorder (MOUD), such as buprenorphine, the number of opioid overdoses in the United States continues to rise.
Benjamin Lai   +2 more
doaj   +1 more source

Emergency Department Buprenorphine Quality Improvement and Emergency Physician Knowledge, Attitudes, and Self-Efficacy

open access: yesWestern Journal of Emergency Medicine, 2023
Objective: Buprenorphine is an evidence-based treatment for opioid use disorder that is underused in the emergency department (ED). In this study we evaluated changes in emergency physician knowledge, confidence, and self-efficacy regarding buprenorphine
Michelle L. Myles   +5 more
doaj   +1 more source

Adapting low-dose buprenorphine induction to meet patient needs: A pilot study

open access: yesDrug and Alcohol Dependence Reports, 2022
Introduction: Low-dose buprenorphine induction (LDBI) has been proposed to initiate buprenorphine in patients who are taking full opioid agonists in order to limit the risk of precipitated withdrawal.
Zoe A. Karavolis, Payel J. Roy
doaj   +1 more source

A comparative study of intrathecal and epidural buprenorphine using combined spinal-epidural technique for caesarean section

open access: yesIndian Journal of Anaesthesia, 2010
Neuraxial opioids provide excellent analgesia intraoperatively and postoperatively while allowing early ambulation of the patient by sparing sympathetic and motor nerves. A prospective, randomised double blind study was conducted involving 90 patients of
Shaloo Ipe   +5 more
doaj   +1 more source

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2022
Background and aims In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly.
Barrot H. Lambdin   +2 more
doaj   +1 more source

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men [PDF]

open access: yesAddiction and Health, 2018
Background: Buprenorphine sublingual tablets are now available in Iran for opioid detoxification in clinics. Aim of the present study was to compare the efficiency of buprenorphine with buprenorphine/naloxone in short-term detoxification in a group of ...
Hassan Ziaaddini   +4 more
doaj   +1 more source

Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination [PDF]

open access: yesMental Health Clinician
Introduction: Opioid overdose deaths continue to rise despite available safe and efficacious treatments for opioid use disorder, such as buprenorphine. Whereas provider-level access to buprenorphine has improved, community pharmacy-level barriers remain,
Winter Roth, PharmD, BCPP   +1 more
doaj   +1 more source

Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin‐evoked dopamine release in rats

open access: yesNeuropsychopharmacology Reports, 2020
Aims The United States of America is currently in an opioid epidemic. Heroin remains the most lethal opioid option with its death rate increasing by over 500% in the last decade.
Dominic P. Isaacs   +5 more
doaj   +1 more source

Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review

open access: yesWestern Journal of Emergency Medicine, 2020
Introduction: Emergency care providers routinely treat patients with acute presentations and sequelae of opioid use disorder. An emergency physician and pharmacist implemented a protocol using buprenorphine for the treatment of patients with opioid ...
Kathy T. LeSaint   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy